Ambien CR Approval Includes Sleep Maintenance, Long-Term Use

The approval of Sanofi-Aventis' Ambien CR (zolpidem extended-release) includes claims for sleep maintenance and long-term use that will allow the insomnia medication to compete against newer agents

More from Archive

More from Pink Sheet